Related Experiment Videos
Current thoughts on extravasation injuries
1University of Pittsburgh School of Medicine, Division of Plastic Surgery, Allegheny General Hospital, Pennsylvania.
Clinics in Plastic Surgery
|July 1, 1989
Summary
Extravasation of therapeutic agents can lead to skin and soft tissue ulcerations. This study describes pharmacologic and surgical treatments for managing these severe injuries.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Extravasation injuries occur when therapeutic agents leak into surrounding tissues.
- These incidents can result in significant skin and soft tissue damage, including ulceration.
- Effective management is crucial to prevent complications and promote healing.
Purpose of the Study:
- To describe the treatment strategies for skin and soft tissue ulceration caused by therapeutic agent extravasation.
- To provide an overview of current pharmacologic and surgical interventions.
Main Methods:
- Review of existing literature on extravasation injury management.
- Description of pharmacologic agents used in treatment.
- Outline of surgical techniques for debridement and reconstruction.
Main Results:
- Pharmacologic treatments aim to neutralize or dilute the extravasated agent and reduce inflammation.
- Surgical interventions may be necessary for severe cases involving extensive tissue necrosis.
- Timely and appropriate treatment can significantly impact patient outcomes.
Conclusions:
- Management of extravasation-induced ulcerations requires a multidisciplinary approach.
- Both pharmacologic and surgical options play vital roles in treating these complex injuries.
- Further research into novel therapeutic strategies is warranted.